Overview

Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Opicapone